Q2 2026 13F · SEC CIK 1694297
22nw, LP
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $104.7M
- Reported positions
- 14
- Holdings vs S&P 500, 3 yrs
- —
- Assets under management
- $295.6M
22nw, LP is a hedge fund that reported 14 positions worth $104.7M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Insperity Inc Com (NSP, 19.5%), Nektar Therapeutics (NKTR, 18.7%), Stoneridge Inc (SRI, 17.3%).
22nw, LP holdings all 14 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| NSPInsperity Inc Com | 19.5% | +0.0% | $20.4M |
| NKTRNektar Therapeutics | 18.7% | +0.0% | $19.6M |
| SRIStoneridge Inc | 17.3% | +0.0% | $18.1M |
| FOXFFox Factory Hldg Corp | 11.0% | +0.0% | $11.5M |
| CMTCore Molding Tech | 6.2% | +22.8% | $6.5M |
| RGNXRegenxbio Inc | 5.6% | +0.0% | $5.9M |
| CULPCulp Inc | 5.5% | +0.0% | $5.8M |
| RZLTRezolute, Inc. | 4.1% | +0.0% | $4.3M |
| UFIUnifi Inc | 3.9% | +0.0% | $4.0M |
| MLYSMineralys Therapeutics Inc | 2.9% | -74.4% | $3.1M |
| TISITeam Inc | 2.8% | +0.0% | $2.9M |
| ELDNEledon Pharmaceuticals Inc | 2.4% | +0.0% | $2.5M |
| TBCHTurtle Beach Corp | 0.2% | — | $180K |
| LNDCLifecore Biomedical Inc | 0.0% | +0.0% | $6K |
What 22nw, LP bought and sold in Q2 2026, against Q1 2026.
New positions
- TBCH Turtle Beach Corp0.2% of 13F
Added to
- CMT Core Molding Tech+22.8% shares
Reduced
- MLYS Mineralys Therapeutics Inc-74.4% shares
Sold out
- FSTR Foster L B Co Comwas 20.4%
- FARM Farmer Bros Cowas 1.7%
- PFX Phenixfin Corpwas 1.2%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- —
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $104.7M | 14 |
| Q1 2026 | $145.9M | 16 |
| Q4 2025 | $237.6M | 20 |
| Q3 2025 | $212.3M | 21 |
| Q2 2025 | $158.8M | 21 |
| Q1 2025 | $149.1M | 20 |
| Q4 2024 | $158.5M | 16 |
| Q3 2024 | $119.3M | 13 |
| Q2 2024 | $117.2M | 13 |
| Q1 2024 | $116.1M | 13 |
| Q4 2023 | $153.5M | 14 |
| Q3 2023 | $134.6M | 13 |
Questions about 22nw, LP's portfolio
What stocks does 22nw, LP own?
22nw, LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 14 positions worth $104.7M. The largest are Insperity Inc Com (NSP) at 19.5%, Nektar Therapeutics (NKTR) at 18.7%, Stoneridge Inc (SRI) at 17.3%, Fox Factory Hldg Corp (FOXF) at 11.0% and Core Molding Tech (CMT) at 6.2%.
What did 22nw, LP buy last quarter?
In Q2 2026, 22nw, LP added a new position in Turtle Beach Corp (TBCH) and Core Molding Tech (CMT) (+22.8% shares), compared with its Q1 2026 filing.
What did 22nw, LP sell last quarter?
In Q2 2026, 22nw, LP sold all of Foster L B Co Com (FSTR), sold all of Farmer Bros Co (FARM), sold all of Phenixfin Corp (PFX) and Mineralys Therapeutics Inc (MLYS) (-74.4% shares), compared with its Q1 2026 filing.
When is 22nw, LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. 22nw, LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does 22nw, LP manage?
22nw, LP reported $295.6M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $104.7M.